Navigation Links
Access Pharmaceuticals to Conduct Conference Call to Update Financial Community
Date:3/10/2008

DALLAS, March 10 /PRNewswire-FirstCall/ -- ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP) announced today that its management team has scheduled a conference call for March 13, 2008 at 10:00 a.m. ET to update the financial community about the status of its clinical trial programs as well as its business opportunities.

Interested parties may participate in the call by dialing (877) 407-8293; callers outside the U.S. may participate by dialing (201) 689-8349 about 5-10 minutes prior to 10:00 a.m. ET. The conference call will also be available on replay starting at 12:00 noon ET on March 13, 2008, and ending on April 13, 2008. For the replay, U.S. participants please dial (877) 660-6853 (replay account # 294, replay conference #278416). The access number for the replay for callers outside the U.S. is (201) 612-7415 (replay account # 294, replay conference # 278416).

About Access:

Access Pharmaceuticals, Inc. is an emerging biopharmaceutical company that develops and commercializes propriety products for the treatment and supportive care of cancer patients. Access' products include ProLindac(TM), currently in Phase 2 clinical testing of patients with ovarian cancer, and MuGard(TM) for the management of patients with mucositis. The company also has other advanced drug delivery technologies including Cobalamin(TM) -- mediated targeted delivery and oral drug delivery, its proprietary nanopolymer delivery technology based on the natural vitamin B12 uptake mechanism; Angiolix(R), a humanized monoclonal antibody which acts as an anti-angiogenesis factor and is targeted to breast cancer; Prodrax(R), a non-toxic prodrug which is activated in the hypoxic zones of solid tumors to kill cancer cells; Alchemix, a chemotherapeutic agent that combines multiple modes of action to overcome drug resistance. Access is also developing Phenylbutyrate ("PB"), an HDAC inhibitor and differentiating agent currently a Phase 2 clinical candidate. For additiona
'/>"/>

SOURCE Access Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Insmed Provides Update on IPLEX(TM) Expanded Access Program in Italy for the Treatment of Amyotrophic Lateral Sclerosis
2. Childrens Hospital Cancer Study Finds Adolescents and Young Adults Dont Get Same Access to Cutting-Edge Treatment as Younger Patients
3. Access Pharmaceuticals Demonstrates Ability to Significantly Reduce Glucose Levels in Pre-clinical Testing of Cobalamin(TM) Oral Insulin
4. New Analysis from 14 Countries Identifies Drug Access Priorities to Achieve 2010 AIDS Treatment Target
5. Demand for Spanish-Language Cancer Web Materials Quadruples; Internet Resources and Access Remain Scarce
6. Access Pharmaceuticals Announces Two Poster Presentations Reporting Significant Preclinical Data on ProLindac(TM) at the AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference
7. Access Pharmaceuticals to Present Data on ProLindac(TM) at the AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference
8. Anesiva Announces Pivotal Phase 3 Trial of Zingo(TM) Meets Primary Endpoint and Significantly Reduces Venous Access Pain in Adults
9. Hypertension: Journal of the American Heart Association Rapid Access Reports: Hispanics Hypertension Better Controlled With Equal Access to Care
10. Anesiva Completes Enrollment in Phase 3 Clinical Trial of Zingo(TM) to Treat Pain Associated With Venous Access Procedures in Adults
11. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... , July 24, 2014  The American ... is supporting its mission to help address audit ... and exclusive agreement to be the information technology ... As the leading provider of billing and business ... unmatched HME industry expertise to support this important ...
(Date:7/24/2014)... , July 24, 2014  Lazarus Effect, a ... novel interventional devices to facilitate removal of blood ... and Trademark Office has issued a new patent ... the company,s Lazarus Cover TM and ReCover ... ReCover is a single-component stent-retriever (stentriever) with an ...
(Date:7/24/2014)... , July 24, 2014 Research ... "Machine Health Monitoring Market by Product, Component, Application and ... report to their offering. ... market is expected to witness a moderate growth as ... have almost reached the saturation levels. The ...
Breaking Medicine Technology:Brightree Joins AAHomecare as Corporate Partner and IT Lead on HME Audit Key 2Lazarus Effect Receives Notice of Allowance for New US Patent Covering Core Protection Technology 2Machine Health Monitoring (Vibration Monitoring, Thermography, Ultrasound Emission, Lubricating Oil Analysis, Corrosion Monitoring, Motor Current Signature Analysis) Market - Forecast to 2020 2
... U.S. District Court Judge Sidney A. Fitzwater has given ... lawsuit that left hundreds of premature babies with life threatening medical conditions and ... will receive compensation under the settlement. , ... "It took years of litigation and research to pry relevant information from people ...
... June 21 One of the leading cancer centers in ... region to introduce fast and efficient RapidArc® radiotherapy treatments from Varian Medical ... treated nine brain cancer, prostate cancer and head & neck cancer patients ... to roll out the technology for many more indications. , ...
Cached Medicine Technology:Fort Worth Attorney Dwain Dent Comments on Final Judgment in Case That Left Hundreds of Babies Dead or Injured 2Al Amal Hospital in Qatar Commences Treatments Using Fast and Efficient RapidArc Radiotherapy Technology from Varian Medical Systems 2Al Amal Hospital in Qatar Commences Treatments Using Fast and Efficient RapidArc Radiotherapy Technology from Varian Medical Systems 3
(Date:7/24/2014)... (PRWEB) July 24, 2014 While healthcare ... in providing quality interpretation services to non-English speakers within ... down. According to Common Sense Advisory, the language ... to $2.3 billion in 2016 (1); additionally, officials at ... to shift over to video remote interpreting ...
(Date:7/24/2014)... by enabling patients to see the same GP every ... one of several recommendations made in a report published ... , Called ,Primary care factors and unscheduled secondary care: ... compiled by researchers from the University,s Centre for Academic ... the world. They found that patients who saw the ...
(Date:7/24/2014)... said, "Love is composed of a single soul inhabiting ... and your partner were made in heaven for each ... , Psychologists observe that people talk and think ... diversity are some common themes that frame how we ... love as perfect unity ("made for each other," "she,s ...
(Date:7/24/2014)... Island have identified two previously undescribed radiological ... adjustable gastric bands. Adding widespread knowledge of ... band margin by more than 2.4 cm ... an air-fluid,level above the band on a ... them in diagnosing affected bariatric patients. These ...
(Date:7/24/2014)... New Rochelle, NY, July 24, 2014Malcolm K. Brenner, MD, ... his career in basic and clinical research toward understanding ... body,s immune defense system, and developing genetically modified T ... his scientific achievements and leadership in the field, Dr. ... Human Gene Therapy , a peer-reviewed journal from ...
Breaking Medicine News(10 mins):Health News:Stratus Video Interpreting Predicts $1 Billion Market Shift to Video Remote Interpreting by 2016 as Court and Healthcare Systems Heed Cost-Effectiveness 2Health News:Stratus Video Interpreting Predicts $1 Billion Market Shift to Video Remote Interpreting by 2016 as Court and Healthcare Systems Heed Cost-Effectiveness 3Health News:Stratus Video Interpreting Predicts $1 Billion Market Shift to Video Remote Interpreting by 2016 as Court and Healthcare Systems Heed Cost-Effectiveness 4Health News:Seeing the same GP at every visit will reduce emergency department attendance 2Health News:New research: When it hurts to think we were made for each other 2Health News:Malcolm K. Brenner receives Pioneer Award for advances in gene-modified T cells targeting cancer 2
... the initiation of a Phase 2a clinical trial for ... a novel , long-acting PDE-5 inhibitor being developed for ... as Raynaud's, a vasospastic disorder of small blood vessels ... areas such as the fingers and toes. Often triggered ...
... learning have found that boys and girls are different ... ,However, they have suggested that this dissimilar ... co-educational to segregated schools, or vice-versa. ,American ... in NSW, said that the key to this complexity ...
... abattoir, especially because it is afflicted with bovine TB. For a ... a heavy toll of the country's economy and prestige, sending the ... , But the "devout" Hindus of Carmarthenshire, a ... the reasoning of the Wales health authorities. The bull is ...
... kill a billion people this century, 10 times the toll it ... serious action to prevent it . ,Critics of smoking ban ... your lips will immediately kill you. And if you sniff-up someone ... in other words it is all over, forget retiring you will ...
... on the ancient Arctic ponds as well, according to new ... ,These ponds, which lie atop bedrock, freeze solid ... each summer, becoming hot spots of activity in the forbidding ... (a meter) deep and around several hundred feet across, the ...
... manned mission to Mars, it has taken its first shaky steps ... rid of the body of a dead astronaut on a three-year ... on a critically ill astronaut who is using up precious oxygen ... testing to weed out astronauts who might get a disease on ...
Cached Medicine News:Health News:Surface Logix Commences Phase 2a Clinical Trial of SLx-2101 in Raynaud's Disease 2Health News:Boys and Girls are Different by Nature and Learn in Different Ways 2Health News:Shambu With Bovine TB Being Prevented from Slaughter 2Health News:1 Billion People to Be Killed by Smoking 2Health News:Human Induced Global Warming Drying Up Arctic Ponds 2Health News:NASA Gets Ready To Address Tough Questions 2Health News:NASA Gets Ready To Address Tough Questions 3
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: